Impact of whole breast irradiation, endocrine therapy or their combination on outcomes of early-stage, luminal A-like, low-risk, breast cancer patients aged 65 years or over: Insights from the EUSOMA database
Cynthia Aristei(University of Perugia), C. Track(Kepler Universitätsklinikum), Ferdinando Riccardi(Ospedale Antonio Cardarelli), Elisabetta Benozzi(Centro di Riferimento Oncologico), Kwok‐Leung Cheung(University of Nottingham), Carla Cedolini(Ospedale Santa Maria della Misericordia di Udine), Antonio Ponti(Piedmont Reference Center for Epidemiology and Cancer Prevention), Jenny Heiman(Sahlgrenska University Hospital), Matteo Ghilli, Francesca Pellini, Alessandra Gennari(Ente Ospedaliero Ospedali Galliera), Giovanna Romanucci, Boudewijn Dullens(AZ Klina), Barbara Bussels(Cambridge Collaborative (United States)), Evelyn Despierre(KU Leuven), Donatella Santini(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Gianluca Fogazzi(University of Brescia), Lucio Fortunato(Azienda Ospedaliera San Giovanni Addolorata), S. Marquette(Jessa Hospital), Olaf Hartmann(Akershus University Hospital), Gracienne Staelens(AZ Groeninge), Serena Scomersi(Scuola Internazionale Superiore di Studi Avanzati), Lorenza Marotti, Mariano Tomatis(European School of Oncology), Frank Cornélis(Cliniques Universitaires Saint-Luc), Karol Rogowski(Medical University of Białystok), Concetta Blundo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), José Luís Fougo(Hospital de São João), Elzbieta Senkus(Gdańsk Medical University), Katia Cagossi(Azienda Unita' Sanitaria Locale Di Modena), Chiara A.P. Anghelone(Policlinico San Matteo Fondazione), Daniele Generali(Azienda Socio Sanitaria Territoriale Lariana), Catarina R. Santos(University of Lisbon), Niccolò M.L. Battisti(Royal Marsden NHS Foundation Trust), Peter van Dam(Antwerp University Hospital), Simona Grossi(Agenzia Sanitaria Regionale Abruzzo), Francesco Caruso(University of Catania), Huscher Alessandra(Fondazione Poliambulanza Istituto Ospedaliero), Patrizia Goiacobazzi(University of Modena and Reggio Emilia), Francesco Sardanelli(Lega Italiana per la Lotta ai Tumori), Sara Pia Colangione(Ospedale Infermi di Rimini), Giuseppe Curigliano(European Institute of Oncology), Romano Polato(Ospedale di Bolzano), Javier Morales(Champalimaud Foundation), Annemie Prové(GZA Ziekenhuizen Campus Sint-Augustinus), Fabio Corsi(University of Milan), Henk Loobuyck(AZ Sint-Lucas), Alessio Schirone, Isabel T. Rubio(Clinica Universidad de Navarra), A. Baldissera(Laboratoire National de Référence)
Cited by 0
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906